Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR2 | O95136 | 1/20 | 0.48 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.48 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.48 |
| ▸ | DPP4 | P27487 | 1/20 | 0.46 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.46 |
| ▸ | PPARG | P37231 | 7/20 | 0.46 |
| ▸ | PPARD | Q03181 | 7/20 | 0.46 |
| ▸ | PPARA | Q07869 | 7/20 | 0.46 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.46 |
| ▸ | TSHR | P16473 | 4/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | TLR2 | O60603 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | FABP4 | P15090 | 2/20 | 0.46 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.46 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.46 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.46 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6659262 | 1.00 | S1PR2 (0.48) | S1PR2S1PR1S1PR3DPP4DPP9 | |
| SCHEMBL7571303 | 1.00 | S1PR2 (0.48) | S1PR2S1PR1S1PR3DPP4DPP9 | |
| SCHEMBL2784601 | 1.00 | S1PR2 (0.48) | S1PR2S1PR1S1PR3DPP4DPP9 | |
| SCHEMBL6659268 | 1.00 | S1PR2 (0.48) | S1PR2S1PR1S1PR3DPP4DPP9 | |
| SCHEMBL7565141 | 1.00 | S1PR2 (0.48) | S1PR2S1PR1S1PR3DPP4DPP9 | |
| SCHEMBL7565565 | 1.00 | S1PR2 (0.48) | S1PR2S1PR1S1PR3DPP4DPP9 | |
| SCHEMBL7571298 | 1.00 | S1PR2 (0.48) | S1PR2S1PR1S1PR3DPP4DPP9 | |
| SCHEMBL7572689 | 1.00 | S1PR2 (0.48) | S1PR2S1PR1S1PR3DPP4DPP9 | |
| SCHEMBL7565560 | 1.00 | S1PR2 (0.48) | S1PR2S1PR1S1PR3DPP4DPP9 | |
| SCHEMBL7565144 | 1.00 | S1PR2 (0.48) | S1PR2S1PR1S1PR3DPP4DPP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1146855-A4 | THERAPEUTIC DELIVERY USING COMPOUNDS SELF-ASSEMBLED INTO HIGH AXIAL RATIO MICROSTRUCTURES | UNIV WASHINGTON (US) | 2004-06-16 | — | — | EP | claimed |
| WO-2001097758-A2 | TEMPERATURE-STABLE POLYAMIDE RESIN-BASED COMPOSITION, AND PRODUCTS | COSMOLAB, INC. (US) | 2001-12-27 | — | — | WO | claimed |
| EP-1146855-A1 | THERAPEUTIC DELIVERY USING COMPOUNDS SELF-ASSEMBLED INTO HIGH AXIAL RATIO MICROSTRUCTURES | University of Washington (US) | 2001-10-24 | — | — | EP | claimed |
| US-6180114-B1 | A DEVICE-FREE METHOD BY WHICH LIGANDS, SUCH AS DRUGS, CAN BE RELEASED INTO THE BODY, PARTICULARLY IN CONTINUOUS MANNER THROUGH ASSOCIATION WITH HIGH AXIAL RATIO MICROSTRUCTURES (HARMS) | UNIVERSITY OF WASHINGTON | 2001-01-30 | — | — | US | claimed |
| WO-2000037046-A1 | THERAPEUTIC DELIVERY USING COMPOUNDS SELF-ASSEMBLED INTO HIGH AXIAL RATIO MICROSTRUCTURES | UNIVERSITY OF WASHINGTON (US) | 2000-06-29 | — | — | WO | claimed |
| EP-0952812-A1 | GEL COMPOSITIONS CONTAINING GELLANTS IN THE FORM OF ALKYL AMIDES OF TRI-CARBOXYLIC ACIDS | THE PROCTER & GAMBLE COMPANY (US) | 1999-11-03 | — | — | EP | claimed |
| WO-1998027948-A1 | GEL COMPOSITIONS CONTAINING GELLANTS IN THE FORM OF ALKYL AMIDES OF TRI-CARBOXYLIC ACIDS | THE PROCTER & GAMBLE COMPANY (US) | 1998-07-02 | — | — | WO | claimed |
| EP-1146855-A4 | THERAPEUTIC DELIVERY USING COMPOUNDS SELF-ASSEMBLED INTO HIGH AXIAL RATIO MICROSTRUCTURES | UNIV WASHINGTON (US) | 2004-06-16 | — | — | EP | disclosed |
| US-20020127192-A1 | Lipstick with translucent or transparent region | COSMOLAB, INC. | 2002-09-12 | — | — | US | disclosed |
| US-6423324-B1 | COSMETICS | COSMOLAB, INC. | 2002-07-23 | — | — | US | disclosed |
| WO-2001097758-A2 | TEMPERATURE-STABLE POLYAMIDE RESIN-BASED COMPOSITION, AND PRODUCTS | COSMOLAB, INC. (US) | 2001-12-27 | — | — | WO | disclosed |
| EP-1146855-A1 | THERAPEUTIC DELIVERY USING COMPOUNDS SELF-ASSEMBLED INTO HIGH AXIAL RATIO MICROSTRUCTURES | University of Washington (US) | 2001-10-24 | — | — | EP | disclosed |
| US-6180114-B1 | A DEVICE-FREE METHOD BY WHICH LIGANDS, SUCH AS DRUGS, CAN BE RELEASED INTO THE BODY, PARTICULARLY IN CONTINUOUS MANNER THROUGH ASSOCIATION WITH HIGH AXIAL RATIO MICROSTRUCTURES (HARMS) | UNIVERSITY OF WASHINGTON | 2001-01-30 | — | — | US | disclosed |
| WO-2000037046-A1 | THERAPEUTIC DELIVERY USING COMPOUNDS SELF-ASSEMBLED INTO HIGH AXIAL RATIO MICROSTRUCTURES | UNIVERSITY OF WASHINGTON (US) | 2000-06-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020127192-A1 | Lipstick with translucent or transparent region | HNRNPK, LMTK2, L3MBTL1 | S1PR2 4348/4885S1PR1 4485/4885S1PR3 4073/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.